Benomyl is of low toxicity to mammals. It has an arbitrary LD50 of "greater than 10,000 mg/kg/day for rats". Skin
irritation may occur through industrial exposure, and
florists, mushroom pickers and
floriculturists have reported allergic reactions to benomyl. In a laboratory study, dogs fed benomyl in their diets for three months developed no major toxic effects, but did show evidence of altered
liver function at the highest dose (150 mg/kg). With longer exposure, more severe liver damage occurred, including
cirrhosis. The
US Environmental Protection Agency classified benomyl as a possible
carcinogen. Carcinogenic studies have produced conflicting results. A two-year experimental study on mice has shown it "probably" causes an increase in liver tumours. The British
Ministry of Agriculture Fisheries and Food took the view this was brought about by the hepatotoxic effect of benomyl. In regards to occupational exposures to benomyl, the
Occupational Safety and Health Administration has set a
permissible exposure limit of 15 mg/m3 for total exposure over an eight-hour time-weighted average, and 5 mg/m3 for respiratory exposures.
Birth defects In 1996, a
Miami jury awarded US$4 million to a child whose mother was exposed in pregnancy to Benlate. The child was born with severe eye defects (clinical
anophthalmia). The mother had been exposed to an unusually high dose of this compound through her exposure from a nearby farm, during pregnancy. An important issue in the case was the timing and magnitude of exposure. In October 2008, DuPont paid confidential settlements to two
New Zealand families whose children were born with various birth defects. The mother of one of the children had been exposed to Benlate while working as a
Christchurch parks worker before his birth. ==Environmental effects==